ALK and neuroblastoma: Taken together, the repotrectinib inhibition profiles observed for ALK-Y1604 phosphorylation and ALK driven PC-12 cell neurite outgrowth show that this ALK TKI is able to inhibit a wide range of active ALK neuroblastoma mutants.